Literature DB >> 19233458

Expression of VEGF-receptor system in conceptus during peri-implantation period and endometrial and luteal expression of soluble VEGFR-1 in the pig.

M M Kaczmarek1, J Kiewisz, D Schams, A J Ziecik.   

Abstract

In view of the importance of vascular events observed during gestation, it was hypothesized that the VEGF-receptor system plays a critical role during early pregnancy and maternal recognition of pregnancy in pigs. This hypothesis was tested by examining the expression of the VEGF-receptor system in the porcine conceptus. Additionally, the endometrium, corpus luteum (CL) and embryos were studied for the expression of soluble VEGF receptor 1 (sVEGFR-1), the strong endogenous antagonist of VEGF. The expression patterns show that VEGF164 mRNA levels increase gradually in line with conceptus development, whereas VEGF120 and VEGFR-2 remain unchanged during the peri-implantation period. Interestingly, elevated VEGFR-1 expression was observed in conceptuses on days 15-16 of gestation (P<0.05). Comparison of the endometrial sVEGFR-1 mRNA expression revealed up-regulation on days 12 and 15-16 of pregnancy (P<0.01 and P<0.05, respectively). Furthermore, increased sVEGFR-1 levels were observed on day 12 of the estrous cycle in the CL (P<0.05). Concluding, it seems that conceptus-derived VEGF164 plays crucial role in peri-implantation vascular events in pigs. These results support a potential role of VEGFR-1 in the proper growth and development of porcine conceptus during pregnancy. Moreover, expression patterns of sVEGFR-1 in the endometrium of pregnant pigs suggest that it may participate in vascular remodeling important for successful implantation. Finally, luteal sVEGFR-1 may be involved in the maintenance of CL function whenever pregnancy occurs in pigs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233458     DOI: 10.1016/j.theriogenology.2008.12.022

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.

Authors:  H R Nejabati; A Mota; L Farzadi; M Ghojazadeh; A Fattahi; K Hamdi; M Nouri
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

Review 2.  Cytokines from the pig conceptus: roles in conceptus development in pigs.

Authors:  Rodney D Geisert; Matthew C Lucy; Jeffrey J Whyte; Jason W Ross; Daniel J Mathew
Journal:  J Anim Sci Biotechnol       Date:  2014-11-07

3.  Uterine Insulin Sensitivity Defects Induced Embryo Implantation Loss Associated with Mitochondrial Dysfunction-Triggered Oxidative Stress.

Authors:  Meixia Chen; Jie Li; Bo Zhang; Xiangfang Zeng; Xiangzhou Zeng; Shuang Cai; Qianhong Ye; Guangxin Yang; Changchuan Ye; Lijun Shang; Shiyan Qiao
Journal:  Oxid Med Cell Longev       Date:  2021-04-12       Impact factor: 6.543

4.  Influence of Genotype on Endometrial Angiogenesis during Early Pregnancy in Piau and Commercial Line Gilts.

Authors:  José Carlos Montes-Vergara; Jurandy Mauro Penitente-Filho; Mariana Machado-Neves; Lucas Corrêa Martins Machado; Faider Alberto Castaño-Villadiego; Karine Assis Costa; Eduardo Paulino da Costa; Carolina Filardi de Campos; Camilo José Ramírez-López; Simone Eliza Facioni Guimarães; Paulo Sávio Lopes; José Domingos Guimarães
Journal:  Animals (Basel)       Date:  2022-02-23       Impact factor: 2.752

5.  Prokineticin 1-prokineticin receptor 1 signaling in trophoblast promotes embryo implantation and placenta development.

Authors:  Ewelina Goryszewska-Szczurek; Monika Baryla; Piotr Kaczynski; Agnieszka Waclawik
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

6.  Peroxisome proliferator‑activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor‑ and angiopoietin‑mediated signaling.

Authors:  Juzuo Zhang; Xuan Peng; Anwen Yuan; Yang Xie; Qing Yang; Liqun Xue
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.